CS
Chetan Sandhu
About Chetan Sandhu
Data last updated:
Chetan Sandhu is a Director at Synoscot Biotech Private Limited (since 2022). The companies operate in Trading and Pharma. Synoscot Biotech Private Limited reported revenue of ₹2.92 Cr (FY 2025). Earlier, Chetan Sandhu was a Director at Jaxrane Remedies Private Limited (2021–2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Mar 2022 | 2022 | ₹2.92 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Feb 2021 | 2021 | ₹3.02 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Chetan Sandhu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Jaspreet Singh | 09536519 | Synoscot Biotech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chetan Sandhu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chetan Sandhu
Chetan Sandhu currently holds 1 directorship: Synoscot Biotech Private Limited (Director, since 15 Mar 2022, revenue ₹2.92 Cr (FY 2025)).
Chetan Sandhu was first appointed on 10 Feb 2021 as Director at Jaxrane Remedies Private Limited. The most recent appointment on record is 15 Mar 2022 at Synoscot Biotech Private Limited.
Chetan Sandhu held 1 earlier board appointment: Jaxrane Remedies Private Limited (Director, 10 Feb 2021 to 21 Feb 2022).
The current boards of Chetan Sandhu's companies include Jaspreet Singh (Synoscot Biotech Private Limited).